INCYTE CORPORATION Research and Development Expense
INCYTE CORPORATION (INCY) reported Research and Development Expense of $515.90 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-28
- INCYTE CORPORATION research and development expense for the quarter ending 2026-03-31 was $515.90M, a 17.98% increase year-over-year.
- INCYTE CORPORATION research and development expense for the quarter ending 2025-12-31 was $611.37M, a 31.19% increase year-over-year.
- INCYTE CORPORATION research and development expense for the quarter ending 2025-09-30 was $506.58M, a 11.62% decline year-over-year.
- INCYTE CORPORATION research and development expense for the quarter ending 2025-06-30 was $494.92M, a 56.52% decline year-over-year.
- INCYTE CORPORATION research and development expense for fiscal 2025 was $2.05B, a 21.36% decline from fiscal 2024.
- INCYTE CORPORATION research and development expense for fiscal 2024 was $2.61B, a 60.17% increase from fiscal 2023.
- INCYTE CORPORATION research and development expense for fiscal 2023 was $1.63B, a 2.63% increase from fiscal 2022.
- INCYTE CORPORATION research and development expense for fiscal 2022 was $1.59B, a 8.76% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $515.90M 10-Q · filed 2026-04-28 | $1.13B derived: sum of 2 quarters · filed 2026-04-28 | $1.63B derived: sum of 3 quarters · filed 2026-04-28 | $2.13B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-12-31 | $611.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.12B derived: sum of 2 quarters · filed 2026-02-10 | $1.61B derived: sum of 3 quarters · filed 2026-02-10 | $2.05B 10-K · filed 2026-02-10 | ||||
| 2025-09-30 | $506.58M 10-Q · filed 2025-10-28 | $1.00B derived: sum of 2 quarters · filed 2025-10-28 | $1.44B 10-Q · filed 2025-10-28 | $1.90B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-06-30 | $494.92M 10-Q · filed 2025-07-29 | $932.20M 10-Q · filed 2025-07-29 | $1.40B derived: sum of 3 quarters · filed 2026-04-28 | $1.97B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-03-31 | $437.28M 10-Q · filed 2026-04-28 | $903.31M derived: sum of 2 quarters · filed 2026-04-28 | $1.48B derived: sum of 3 quarters · filed 2026-04-28 | $2.61B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2024-12-31 | $466.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.04B derived: sum of 2 quarters · filed 2026-02-10 | $2.18B derived: sum of 3 quarters · filed 2026-02-10 | $2.61B 10-K · filed 2026-02-10 | ||||
| 2024-09-30 | $573.17M 10-Q · filed 2025-10-28 | $1.71B derived: sum of 2 quarters · filed 2025-10-28 | $2.14B 10-Q · filed 2025-10-28 | $2.59B derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2024-06-30 | $1.14B 10-Q · filed 2025-07-29 | $1.57B 10-Q · filed 2025-07-29 | $2.01B derived: sum of 3 quarters · filed 2026-02-10 | $2.39B derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2024-03-31 | $429.26M 10-Q · filed 2025-04-29 | $873.75M derived: sum of 2 quarters · filed 2026-02-10 | $1.25B derived: sum of 3 quarters · filed 2026-02-10 | $1.65B derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2023-12-31 | $444.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $820.20M derived: sum of 2 quarters · filed 2026-02-10 | $1.22B derived: sum of 3 quarters · filed 2026-02-10 | $1.63B 10-K · filed 2026-02-10 | ||||
| 2023-09-30 | $375.71M 10-Q · filed 2024-10-29 | $776.46M derived: sum of 2 quarters · filed 2024-10-29 | $1.18B 10-Q · filed 2024-10-29 | $1.68B derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-06-30 | $400.75M 10-Q · filed 2024-07-30 | $807.39M 10-Q · filed 2024-07-30 | $1.31B derived: sum of 3 quarters · filed 2025-02-10 | $1.69B derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-03-31 | $406.64M 10-Q · filed 2024-04-30 | $908.00M derived: sum of 2 quarters · filed 2025-02-10 | $1.29B derived: sum of 3 quarters · filed 2025-02-10 | $1.64B derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2022-12-31 | $501.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $885.37M derived: sum of 2 quarters · filed 2025-02-10 | $1.23B derived: sum of 3 quarters · filed 2025-02-10 | $1.59B 10-K · filed 2025-02-10 | ||||
| 2022-09-30 | $384.01M 10-Q · filed 2023-10-31 | $731.20M derived: sum of 2 quarters · filed 2023-10-31 | $1.08B 10-Q · filed 2023-10-31 | $1.56B derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-06-30 | $347.20M 10-Q · filed 2023-08-01 | $700.57M 10-Q · filed 2023-08-01 | $1.17B derived: sum of 3 quarters · filed 2024-02-13 | $1.51B derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-03-31 | $353.37M 10-Q · filed 2023-05-02 | $826.20M derived: sum of 2 quarters · filed 2024-02-13 | $1.16B derived: sum of 3 quarters · filed 2024-02-13 | $1.50B derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2021-12-31 | $472.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $807.77M derived: sum of 2 quarters · filed 2024-02-13 | $1.15B derived: sum of 3 quarters · filed 2024-02-13 | $1.46B 10-K · filed 2024-02-13 | ||||
| 2021-09-30 | $334.94M 10-Q · filed 2022-11-01 | $678.46M derived: sum of 2 quarters · filed 2022-11-01 | $985.35M 10-Q · filed 2022-11-01 | $1.39B derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2021-06-30 | $343.51M 10-Q · filed 2022-08-02 | $650.41M 10-Q · filed 2022-08-02 | $1.06B derived: sum of 3 quarters · filed 2023-02-07 | $1.49B derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2021-03-31 | $306.90M 10-Q · filed 2022-05-03 | $712.84M derived: sum of 2 quarters · filed 2023-02-07 | $1.15B derived: sum of 3 quarters · filed 2023-02-07 | $1.44B derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2020-12-31 | $405.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $844.05M derived: sum of 2 quarters · filed 2023-02-07 | $1.13B derived: sum of 3 quarters · filed 2023-02-07 | $2.22B 10-K · filed 2023-02-07 | ||||
| 2020-09-30 | $438.11M 10-Q · filed 2021-11-02 | $724.71M derived: sum of 2 quarters · filed 2021-11-02 | $1.81B 10-Q · filed 2021-11-02 | $2.12B derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2020-06-30 | $286.60M 10-Q · filed 2021-08-03 | $1.37B 10-Q · filed 2021-08-03 | $1.68B derived: sum of 3 quarters · filed 2022-02-08 | $1.97B derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2020-03-31 | $1.09B 10-Q · filed 2021-05-04 | $1.40B derived: sum of 2 quarters · filed 2022-02-08 | $1.68B derived: sum of 3 quarters · filed 2022-02-08 | $1.97B derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2019-12-31 | $312.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $594.20M derived: sum of 2 quarters · filed 2022-02-08 | $883.57M derived: sum of 3 quarters · filed 2022-02-08 | $1.15B 10-K · filed 2022-02-08 | ||||
| 2019-09-30 | $281.34M 10-Q · filed 2020-11-05 | $570.70M derived: sum of 2 quarters · filed 2020-11-05 | $841.24M 10-Q · filed 2020-11-05 | $1.15B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-06-30 | $289.36M 10-Q · filed 2020-08-04 | $559.91M 10-Q · filed 2020-08-04 | $864.15M derived: sum of 3 quarters · filed 2021-02-09 | $1.16B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-03-31 | $270.55M 10-Q · filed 2020-05-05 | $574.78M derived: sum of 2 quarters · filed 2021-02-09 | $867.31M derived: sum of 3 quarters · filed 2021-02-09 | $1.17B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2018-12-31 | $304.24M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $596.76M derived: sum of 2 quarters · filed 2021-02-09 | $894.85M derived: sum of 3 quarters · filed 2021-02-09 | $1.20B 10-K · filed 2021-02-09 | ||||
| 2018-09-30 | $292.53M 10-Q · filed 2019-10-29 | $590.62M derived: sum of 2 quarters · filed 2019-10-29 | $893.72M 10-Q · filed 2019-10-29 | $1.34B derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $298.09M 10-Q · filed 2019-07-30 | $601.19M 10-Q · filed 2019-07-30 | $1.05B derived: sum of 3 quarters · filed 2020-02-13 | $1.32B derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $303.10M 10-Q · filed 2019-04-30 | $749.97M derived: sum of 2 quarters · filed 2020-02-13 | $1.02B derived: sum of 3 quarters · filed 2020-02-13 | $1.22B derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $446.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $716.43M derived: sum of 2 quarters · filed 2020-02-13 | $918.21M derived: sum of 3 quarters · filed 2020-02-13 | $1.33B 10-K · filed 2020-02-13 | $1.33B 10-K · filed 2018-02-15 | |||
| 2017-09-30 | $269.56M 10-Q · filed 2018-10-30 | $269.61M 10-Q · filed 2017-10-31 | $471.34M derived: sum of 2 quarters · filed 2018-10-30 | $879.26M 10-Q · filed 2018-10-30 | $879.42M 10-Q · filed 2017-10-31 | $1.04B derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-06-30 | $201.79M 10-Q · filed 2018-07-31 | $201.84M 10-Q · filed 2017-08-01 | $609.71M 10-Q · filed 2018-07-31 | $609.81M 10-Q · filed 2017-08-01 | $771.29M derived: sum of 3 quarters · filed 2019-02-14 | $914.48M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-03-31 | $407.92M 10-Q · filed 2018-05-01 | $407.97M 10-Q · filed 2017-05-04 | $569.50M derived: sum of 2 quarters · filed 2019-02-14 | $712.69M derived: sum of 3 quarters · filed 2019-02-14 | $832.96M derived: sum of 4 quarters · filed 2019-02-14 | |||
| 2016-12-31 | $161.59M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $304.77M derived: sum of 2 quarters · filed 2019-02-14 | $425.04M derived: sum of 3 quarters · filed 2019-02-14 | $581.86M 10-K · filed 2019-02-14 | ||||
| 2016-09-30 | $143.18M 10-Q · filed 2017-10-31 | $263.45M derived: sum of 2 quarters · filed 2017-10-31 | $420.28M 10-Q · filed 2017-10-31 | $536.91M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $120.27M 10-Q · filed 2017-08-01 | $277.09M 10-Q · filed 2017-08-01 | $393.73M derived: sum of 3 quarters · filed 2018-02-15 | $525.80M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $156.82M 10-Q · filed 2017-05-04 | $273.46M derived: sum of 2 quarters · filed 2018-02-15 | $405.53M derived: sum of 3 quarters · filed 2018-02-15 | $517.97M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $116.63M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $248.71M derived: sum of 2 quarters · filed 2018-02-15 | $361.15M derived: sum of 3 quarters · filed 2018-02-15 | $479.51M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $132.07M 10-Q · filed 2016-11-01 | $244.52M derived: sum of 2 quarters · filed 2016-11-01 | $362.88M 10-Q · filed 2016-11-01 | $461.60M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-06-30 | $112.44M 10-Q · filed 2016-08-09 | $230.81M 10-Q · filed 2016-08-09 | $329.53M derived: sum of 3 quarters · filed 2017-02-14 | $418.06M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-03-31 | $118.36M 10-Q · filed 2016-05-09 | $217.08M derived: sum of 2 quarters · filed 2017-02-14 | $305.62M derived: sum of 3 quarters · filed 2017-02-14 | $390.30M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2014-12-31 | $98.72M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $187.25M derived: sum of 2 quarters · filed 2017-02-14 | $271.94M derived: sum of 3 quarters · filed 2017-02-14 | $347.52M 10-K · filed 2017-02-14 | ||||
| 2014-09-30 | $88.54M 10-Q · filed 2015-11-03 | $173.22M derived: sum of 2 quarters · filed 2015-11-03 | $248.81M 10-Q · filed 2015-11-03 | $323.82M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-06-30 | $84.68M 10-Q · filed 2015-08-04 | $160.27M 10-Q · filed 2015-08-04 | $235.29M derived: sum of 3 quarters · filed 2016-02-12 | $306.99M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-03-31 | $75.58M 10-Q · filed 2015-04-30 | $150.60M derived: sum of 2 quarters · filed 2016-02-12 | $222.31M derived: sum of 3 quarters · filed 2016-02-12 | $283.26M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2013-12-31 | $75.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $146.72M derived: sum of 2 quarters · filed 2016-02-12 | $207.67M derived: sum of 3 quarters · filed 2016-02-12 | $260.44M 10-K · filed 2016-02-12 | ||||
| 2013-09-30 | $71.70M 10-Q · filed 2014-10-30 | $132.65M derived: sum of 2 quarters · filed 2014-10-30 | $185.42M 10-Q · filed 2014-10-30 | $245.18M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-06-30 | $60.95M 10-Q · filed 2014-07-31 | $113.71M 10-Q · filed 2014-07-31 | $173.48M derived: sum of 3 quarters · filed 2015-02-17 | $223.56M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-03-31 | $52.76M 10-Q · filed 2014-05-01 | $112.53M derived: sum of 2 quarters · filed 2015-02-17 | $162.61M derived: sum of 3 quarters · filed 2015-02-17 | $214.19M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2012-12-31 | $59.76M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $109.84M derived: sum of 2 quarters · filed 2015-02-17 | $161.43M derived: sum of 3 quarters · filed 2015-02-17 | $210.39M 10-K · filed 2015-02-17 | ||||
| 2012-09-30 | $50.08M 10-Q · filed 2013-10-31 | $101.67M derived: sum of 2 quarters · filed 2013-10-31 | $150.63M 10-Q · filed 2013-10-31 | $202.50M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-06-30 | $51.59M 10-Q · filed 2013-08-01 | $100.55M 10-Q · filed 2013-08-01 | $152.43M derived: sum of 3 quarters · filed 2014-02-21 | $197.03M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-03-31 | $48.96M 10-Q · filed 2013-05-02 | $100.84M derived: sum of 2 quarters · filed 2014-02-21 | $145.44M derived: sum of 3 quarters · filed 2014-02-21 | $191.49M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2011-12-31 | $51.88M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $96.48M derived: sum of 2 quarters · filed 2014-02-21 | $142.53M derived: sum of 3 quarters · filed 2014-02-21 | $178.71M 10-K · filed 2014-02-21 | ||||
| 2011-09-30 | $44.60M 10-Q · filed 2012-11-01 | $90.65M derived: sum of 2 quarters · filed 2012-11-01 | $126.83M 10-Q · filed 2012-11-01 | $159.71M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | $46.05M 10-Q · filed 2012-08-03 | $82.33M 10-Q · filed 2012-08-03 | $115.10M derived: sum of 3 quarters · filed 2013-02-21 | $145.71M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | $36.28M 10-Q · filed 2012-04-26 | $69.06M derived: sum of 2 quarters · filed 2013-02-21 | $99.67M derived: sum of 3 quarters · filed 2013-02-21 | $128.55M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | $32.77M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $63.38M derived: sum of 2 quarters · filed 2013-02-21 | $92.27M derived: sum of 3 quarters · filed 2013-02-21 | $123.88M 10-K · filed 2013-02-21 | ||||
| 2010-09-30 | $30.61M 10-Q · filed 2011-10-27 | $59.49M derived: sum of 2 quarters · filed 2011-10-27 | $91.11M 10-Q · filed 2011-10-27 | |||||
| 2010-06-30 | $28.88M 10-Q · filed 2011-07-28 | $60.32M 10-Q · filed 2011-07-28 | ||||||
| 2010-03-31 | $31.44M 10-Q · filed 2011-05-03 | |||||||
| 2009-12-31 | $119.44M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |